From: Evaluation of hypoglycemic and anti-hyperglycemic potential of Tridax procumbens (Linn.)
Group (n = 6) | Dose (mg/kg b wt) | Blood Glucose levels (mg/dl) | |||||
---|---|---|---|---|---|---|---|
 |  | -30 min | 0 min | 30 min | 60 min | 90 min | 120 min |
Normal Control | - | 79.12 ± 2.8a | 80.16 ± 3.6a | 146.5 ± 9.6b | 152.4 ± 8.4b | 121.6 ± 21.6c | 102.3 ± 32.0d |
Normal+ Extract | 250 | 78.54 ± 4.1a | 76.60 ± 3.0a | 151.0 ± 11.7b | 143.6 ± 9.6b | 119.2 ± 16.3c | 87.5 ± 12.3d |
Normal+ Extract | 500 | 79.58 ± 3.2a | 73.60 ± 5.8a | 149.4 ± 8.2b | 136.6 ± 11.0c | 120.6 ± 11.6c | 84.6 ± 19.0d |
Diabetic Control | - | 508.2 ± 4.7a | 512.40 ± 9.6a | HIb | 597.2 ± 3.4b | 580.6 ± 32.0b | 547.5 ± 9.2c |
Diabetic+ Extract | 250 | 186.6 ± 2.4a | 181.24 ± 12.5a | 299.8 ± 43.0b | 261.0 ± 34.2c | 196.4 ± 14.9d | 169.6 ± 14.4e |
Diabetic+ Extract | 500 | 163.0 ± 6.8a | 165.00 ± 10.2a | 302.4 ± 19.6b | 271.0 ± 18.3c | 190.4 ± 28.4d | 160.3 ± 18.4e |
Diabetic+ Glibenc-lamide | 10 | 190.4 ± 4.6a | 190.00 ± 11.4a | 285.6 ± 46.0b | 256.6 ± 29.4c | 231.0 ± 17.2c | 199.6 ± 10.3d |